Financial Advocates Investment Management acquired a new stake in shares of Canopy Growth Co. (NASDAQ:CGC – Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 11,773 shares of the company’s stock, valued at approximately $57,000.
Several other hedge funds have also recently added to or reduced their stakes in the business. PFG Investments LLC acquired a new stake in shares of Canopy Growth in the 3rd quarter valued at $54,000. CIBC Asset Management Inc acquired a new position in shares of Canopy Growth during the second quarter worth approximately $91,000. Vontobel Holding Ltd. bought a new stake in Canopy Growth in the third quarter valued at approximately $92,000. Insigneo Advisory Services LLC bought a new stake in Canopy Growth in the second quarter valued at approximately $96,000. Finally, Genesee Capital Advisors LLC increased its position in shares of Canopy Growth by 15.3% during the second quarter. Genesee Capital Advisors LLC now owns 15,047 shares of the company’s stock worth $97,000 after acquiring an additional 2,000 shares in the last quarter. Institutional investors and hedge funds own 3.33% of the company’s stock.
Canopy Growth Trading Up 13.0 %
Shares of Canopy Growth stock opened at $5.49 on Tuesday. The firm has a market capitalization of $515.31 million, a PE ratio of -0.78 and a beta of 0.87. The company has a current ratio of 2.15, a quick ratio of 1.64 and a debt-to-equity ratio of 1.05. The firm’s 50 day moving average is $4.71 and its 200 day moving average is $6.71. Canopy Growth Co. has a 1 year low of $2.76 and a 1 year high of $14.92.
Wall Street Analysts Forecast Growth
Separately, Piper Sandler cut their target price on shares of Canopy Growth from $3.00 to $2.00 and set an “underweight” rating for the company in a research note on Tuesday, July 9th.
View Our Latest Research Report on CGC
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
Read More
- Five stocks we like better than Canopy Growth
- What is a SEC Filing?
- Intel: Is Now the Time to Be Brave?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Earnings Per Share Calculator: How to Calculate EPS
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.